ATRAptarGroup, Inc.

$124.37
Latest close: below its 200-day averageSep 8, 2026what changed →

Is the price fair?

What ATR's price assumes

AptarGroup, Inc. trades at 22.4× earnings against 40.2× for the median Medical Instruments & Supplies name, cheaper than its own group.

22.4

Trailing P/E · Medical Instruments & Supplies median 40.2 · cheaper than the typical name in its group

Price / sales
2.10

Price / sales · as of 2026-Q1

Free cash flow yield
3.9%

Free cash flow yield · Medical Instruments & Supplies median 3.7%

Growth the price implies
+9.1%

Growth the price implies · The price pays for +9.1% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.

Details
Price / book2026-Q1
3.09
Healthcare median P/E362 names
29.9
Medical Instruments & Supplies median P/E29 names
40.2
Free cash flow, trailing twelve months
$310M
Market capitalisation
$8.07B
3-year revenue growth
+5.1%
3-year free cash flow growth
+23%
What the market has paid for these earnings: 38 quarters of its own multiple × $5.54 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$140.80
Its own P/E history, median$162.14
Its own P/E history, upper quartile$172.81
52-week range$111.94 – $145.15
Today$124.37

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.